Scientific Program

Conference Series Ltd invites all the participants across the globe to attend 2nd Annual Congress on Bacterial, Viral and Infectious Diseases Dubai, UAE.

Day 2 :

Keynote Forum

Stef Stienstra

Dutch ArmedForces, The Netherlands

Keynote: Drug delivery by tattooing to treat cutaneous leishmaniasis

Time : 09:00-09:40

OMICS International Bacterial Diseases 2019 International Conference Keynote Speaker Stef Stienstra photo

Stef Stienstra has been working internationally for several medical and biotech companies as Scientific Advisory Board Member and is also
an active Reserve-Officer of the Royal Dutch Navy in his rank as Commander (OF4). He is a Visiting Professor for the University of Rome Tor Vergata in Italy and Lecturer for the NATO School in Oberammergau in Germany


Leishmaniasis is a vector-borne disease that is caused by obligate intra-macrophage protozoa of the Leishmania species. Leishmaniasis can cause different clinical syndromes, including Cutaneous Leishmaniasis (CL) in which the patient generally presents with one or several ulcer(s) or nodule(s) on the skin, resulting from the infection of phagocytic cells located in the dermis. It often results into severe scar tissue in the skin. Most of the twelve million people infected with Leishmania worldwide are CL cases, a 1.5 million new cases occur annually. WHO has a program to develop new treatments for cutaneous leishmaniasis. This study establishes a proof-of-concept that a tattoo device can target intra-dermal drug delivery against Cutaneous Leishmaniasis (CL). The selected drug is Oleylphosphocholine (OlPC) formulated as liposomes, particles known to be prone to macrophage ingestion. First is shown that treatment of cultured Leishmania-infected macrophages with OlPC-liposomes results in a direct dose-dependent killing of intracellular parasites. Based on this, in vivo efficacy is demonstrated using a 10-day tattooing-mediated treatment in mice infected with L. major and L. mexicana. In both models this regimen results in rapid clinical recovery with complete regression of skin lesions by Day 28. Parasite counts and histopathology examination confirm high treatment efficacy at the parasitic level

Keynote Forum

Mohamad Miqdady

Sheikh Khalifa Medical City, UAE

Keynote: Congenital diarrhea syndromes

Time : 09:40-10:20

OMICS International Bacterial Diseases 2019 International Conference Keynote Speaker Mohamad Miqdady photo

Mohamad Miqdady is American Board certified in Pediatric Gastroenterology, Hepatology and Nutrition. He is the Division Chief, Ped. GI, Hepatology & Nutrition Division at Sheikh Khalifa Medical City in UAE. Program Director, Pediatric Gastroenterology Fellowship Training program, SKMC, Abu Dhabi, UAE. Also an Adjunct Staff at Cleveland Clinic, Ohio USA. Expert member of the FISPGHAN Council (Federation of International Societies of Pediatric Gastroenterology, Hepatology, and Nutrition); Malnutrition/Obesity Expert team.He completed his Fellowship in Pediatric Gastroenterology at Baylor College of Medicine and Texas Children’s Hospital in Houston, TX, USA. He held the
position of Assistant Professor at Jordan University of Science and Technology in Jordan for six years prior joining SKMC.Main research interests include nutritional disorders, feeding difficulties, picky eating, obesity, procedural sedation, allergic GI disorders and celiac disease. He has 20 publications in peer reviewed journals



Congenital diarrhea is a term used to describe diarrhea that develops early in life, typically, within the first two months of life classically associated with dehydration, failure to thrive and electrolyte disturbances. Some of these infants with secretary type might have prenatal findings of dilated bowel loops. While in infants with malabsorptive type it starts with the first feed. The diagnosis is usually established with endoscopic biopsies with electron microscopy evaluation and the appropriate genetic testing. While it might be puzzling and challenging even to the most prudent physician, we will discuss a practical approach that allows you to
have a provisional working diagnosis and management plan helping your infant to back on track in a timely approach. Treatment is usually with long term parenteral nutrition with special attention to avoid long term complication associated with TPN.

Break: 10:20-10:50 Networking and Refreshments Break